Navigation Links
Thomson Reuters and ChemAxon Partner to Help Speed Drug Discovery for Life Science Researchers
Date:1/4/2011

LONDON and BUDAPEST, Hungary, Jan. 4, 2011 /PRNewswire/ -- The IP Solutions business of Thomson Reuters®, the leader in intellectual property research and analysis solutions, and ChemAxon, the leader in cheminformatics software for the life sciences industry, today announced a strategic partnership whereby Thomson Reuters is providing its chemical IP Data Feeds – Markush Structures and patent data to users of ChemAxon's JChem chemical software platform. This search and analysis solution will speed drug discovery and allow life science researchers to easily integrate critical content into their existing systems and workflow.

(Photo:  http://photos.prnewswire.com/prnh/20110104/NY24167)

The Markush structures from Thomson Reuters are part of the company's Derwent World Patents Index® (DWPI(SM)) database, the world's most trusted and authoritative source of global patent information. The Markush database contains essential data on the relationship or "families" of 550,000 patents, making it the world's leading source for life sciences patentability research, competitive intelligence and IP screening.  ChemAxon's JChem software allows life science professionals to structure and visualize chemical compounds for property prediction, virtual synthesis, screening and drug design. Through this partnership R&D end users can now research and analyze Markush structures using ChemAxon's JChem chemical software platform, a means they had no access to before.  The ability to quickly retrieve this information will now allow R&D end users to save time and capitalize on R&D investment.

"The ability to search and visualize complex chemical patents is critical to the work of life science R&D professionals. To date, however, this has been a challenge as there wasn't a tool that enabled R&D end users to do this type of work themselves," said Cindy Poulos, vice president of product management, Thomson Reuters. "Through this partnership, Thomson Reuters and ChemAxon are making a comprehensive worldwide database of chemical compounds widely accessible in a user-friendly, flexible format to end users."

"The Markush structures database has become a vital backbone of pharmaceutical research in the digital age," said Alex Drijver, CEO of ChemAxon.  "By delivering this data directly to the end user in an intuitive, flexible format, our clients have access to the functionality and data necessary to stay competitive in today's fast-paced, complex marketplace."

The Thomson Reuters IP Data Feed - Markush Structures database is indexed from 550,000 patent families, plus 1.7 million related, exemplified, specific compounds.  It includes patents for pharmaceuticals, agrochemicals and general chemistry spanning 26 patent-issuing authorities.  Markush data is integrated with high-quality patent summary data from DWPI, enabling access to enhanced patent abstracts, family and assignee details, and relevant bibliographic data.  For more information, contact Steve Hajkowski, product manager, Thomson Reuters, at steve.hajkowski@thomsonreuters.com

About ChemAxon Ltd

ChemAxon is a leader in providing cheminformatics software development platforms and applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals.  We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, healthcare and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs 55,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Rush-Copley Medical Center Selects Pharmacy Xpert from Thomson Reuters to Improve Medication Management
2. US Dominance in Scientific Research Significantly Challenged by Increased Competition from Europe and Asia, According to Thomson Reuters Study
3. Generic Drug Sector Gets Better Information on API Manufacturing Costs from Thomson Reuters and Rondaxe Enterprises
4. GenomeQuest & Thomson Reuters Host IP Seminar
5. Thomson Reuters Names the Worlds Hottest Researchers
6. Thomson Reuters Launches Academic Reputation Survey as Part of Global Institutional Profiles Project
7. Australia Substantially Increases Research Collaboration with China, According to Thomson Reuters Study
8. Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials
9. Chinas Research Output More Than Doubled Since 2004, Thomson Reuters Study Reveals
10. Thomson Reuters Explores the Opportunities and Challenges of Entering the Japanese Generic Drug Market
11. Thomson Reuters Predicts Nobel Laureates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Andrew D Zelenetz , ... Published recently in Oncology & ... Andrew D Zelenetz , discusses the fact ... placing an increasing burden on healthcare systems worldwide, ... the patents on many biologics expiring, interest in ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining centers ... The result of a collaboration among several companies with expertise in toolholding, cutting ...
(Date:6/23/2016)... ReportsnReports.com adds 2016 global ... pharmaceuticals section with historic and forecast data along ... Complete report on the Cell Culture ... companies and supported with 261 tables and figures ... The Global Cell Culture Media Industry ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
(Date:3/31/2016)... RATON, Florida , March 31, 2016 ... LEGX ) ("LegacyXChange" or the "Company") ... for potential users of its soon to be launched ... video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide ... the use of DNA technology to an industry that ...
Breaking Biology News(10 mins):